News for AbbVie Inc. (ABBV34.SA)

Stock futures indicate a slight dip in the market following a three-day rally driven by optimism surrounding U.S.”“China trade relations and robust corporate e

On CNBC's “Halftime Report Final Trades,” Joshua Brown, CEO and co-founder, Ritholtz Wealth Management, said he is staying long on 3M Company MMM. Supporti...

Top Wall Street analysts changed their outlook on these top names. For a complete view of all analyst rating changes, including upgrades, downgrades and initiat...

We recently published a list of 10 Best Pharma Stocks to Buy for Long Term Growth. In this article, we are going to take a look at where AbbVie Inc.

NEW YORK, April 18, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behal

We recently published a list of 15 Best Large-Cap Value Stocks to Buy as the Recession Hits. In this article, we are going to take a look at where AbbVie Inc. (NYSE:ABBV) stands against other best large-cap value stocks to buy as the recession hits. Goldman Sachs highlighted that equities around the world traded in and […]

AbbVie Inc. showcases strong revenue growth, defying challenges from Humira's patent expiration. Analysts project significant upside potential with an a

NEW YORK, April 17, 2025 (GLOBE NEWSWIRE) -- The Gross Law Firm issues the following notice to shareholders of Cerevel Therapeutics Holdings, Inc. (: ABBV).

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023. In 2023, the healthcare industry made up 17.6% of the US economy, an increase of 17.4% from 2022. The growth of Medicare and private […]

In the US, healthcare costs and prices have been increasing. According to the Centers for Medicare & Medicaid Services, U.S. healthcare spending increased 7.5% from 2022 to $4.9 trillion in 2023.

Enters into Agreement with Bradley L. Radoff and Michael Torok BOSTON, April 17, 2025 (GLOBE NEWSWIRE) -- Atea Pharmaceuticals, Inc. ( AVIR) (”œAtea” or

**media[597920]**

PR NewswireNEW YORK, April 17, 2025 NEW YORK, April 17, 2025 /PRNewswire/ -- The Gross Law Firm issues the following notice to shareholders of Cerevel Ther

SAN DIEGO, April 16, 2025 (GLOBE NEWSWIRE) -- Robbins LLP reminds stockholders that a class action was filed against Cerevel Therapeutics Holdings, Inc. (”œC

Today's Research Daily features new research reports on 16 major stocks, including AbbVie Inc. (ABBV), The TJX Companies, Inc. (TJX) and The Charles Schwab Corporation (SCHW), as well as two micro-cap stocks, Enzo Biochem, Inc. (ENZ) and CVD Equipment Corporation (CVV).

NEW YORK, April 14, 2025 (GLOBE NEWSWIRE) -- WHY: Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behal

On CNBC's “Halftime Report Final Trades,” Kevin Simpson of Capital Wealth Planning said The TJX Companies, Inc. TJX is a standout name in a tough retail env...

Key Takeaways: AbbVie Inc. (ABBV) shares fell 17.74% in the past month, yet the company exceeded earnings expectations. Despite a year-over-year increase

ClearBridge Investments, an investment management company, released its “ClearBridge Growth Strategy” first quarter 2025 investor letter. A copy of the letter can be downloaded here. First quarter of 2025 witnessed sharp equities sell off due to the shift out of mega caps. There was a relative outperformance of mid cap growth stocks over large and […]